Hide metadata

dc.contributor.authorWaldum-Grevbo, Bård
dc.contributor.authorLeivestad, Torbjørn
dc.contributor.authorReisæter, Anna V
dc.contributor.authorOs, Ingrid
dc.date.accessioned2015-11-27T14:09:01Z
dc.date.available2015-11-27T14:09:01Z
dc.date.issued2015
dc.identifier.citationBMC Nephrology. 2015 Oct 30;16(1):179
dc.identifier.urihttp://hdl.handle.net/10852/48024
dc.description.abstractBackground Whether the choice of dialysis modality in patients with end stage renal disease may impact mortality is undecided. No randomized controlled trial has properly addressed this issue. Propensity-matched observational studies could give important insight into the independent effect of peritoneal (PD) opposed to haemodialysis (HD) on all-cause and cardiovascular mortality. Methods To correct for case-mix differences between patients treated with PD and HD, propensity-matched analyses were utilized in all patients who initiated dialysis as first renal replacement therapy in Norway in the period 2005–2012. PD patients were matched in a 1:1 fashion with HD patients, creating 692 pairs of patients with comparable baseline variables. As-treated and intention-to treat analyses were undertaken to assess cardiovascular and all-cause mortality. Interaction analyses were used to assess differences in the relationship between initial dialysis modality and mortality, between strata of age, gender and prevalent diabetes mellitus. Results In the as-treated analyses, initial dialysis modality did not impact 2-year (PD vs. HD: HR 0.87, 95 % CI 0.67–1.12) or 5-year all-cause mortality (HR 0.95, 95 % CI 0.77–1.17). In patients younger than 65 years, PD was superior compared to HD with regard to both 2-year (HR 0.39, 95 % CI 0.19–0.81), and 5-year all-cause mortality (HR 0.49, 95 % CI 0.27–0.89). Cardiovascular mortality was also lower in the younger patients treated with PD (5-year HR 0.38, 95 % CI 0.15–0.96). PD was not associated with impaired prognosis in any of the prespecified subgroups compared to HD. The results were similar in the as-treated and intention-to-treat analyses. Conclusion Survival in PD was not inferior to HD in any subgroup of patients even after five years of follow-up. In patients below 65 years, PD yielded superior survival rates compared to HD. Increased use of PD as initial dialysis modality in ESRD patients could be encouraged.
dc.language.isoeng
dc.rightsWaldum-Grevbo et al.
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleImpact of initial dialysis modality on mortality: a propensity-matched study
dc.typeJournal article
dc.date.updated2015-11-27T14:09:01Z
dc.creator.authorWaldum-Grevbo, Bård
dc.creator.authorLeivestad, Torbjørn
dc.creator.authorReisæter, Anna V
dc.creator.authorOs, Ingrid
dc.identifier.doihttp://dx.doi.org/10.1186/s12882-015-0175-5
dc.identifier.urnURN:NBN:no-51996
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/48024/1/12882_2015_Article_175.pdf
dc.type.versionPublishedVersion
cristin.articleid179


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International